GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 19 Oct 2018, 04:19

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

A new drug to lower cholesterol has entered the market that,

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

SC Moderator
User avatar
V
Joined: 23 Sep 2015
Posts: 1214
GMAT ToolKit User Premium Member Reviews Badge CAT Tests
A new drug to lower cholesterol has entered the market that,  [#permalink]

Show Tags

New post 04 Mar 2018, 08:43
00:00
A
B
C
D
E

Difficulty:

  65% (hard)

Question Stats:

59% (02:19) correct 41% (02:32) wrong based on 89 sessions

HideShow timer Statistics

A new drug to lower cholesterol has entered the market that, when used in combination with existing drugs called statins, can reduce the risk of heart disease more effectively than statins alone. Patients who tried the new drug in a clinical trial were able to lessen their daily dose of statins without a corresponding increase in blood cholesterol levels. Statins alone, however, cost less, and the money patients saved on statins rarely surpassed the added cost of the new drug. Therefore, for most patients with high cholesterol, adding the new drug to their treatment regimen would be unlikely to lower healthcare costs.
Which of the following would it be most helpful to know in order to analyze the argument?
A. Whether there is a type of high cholesterol that can increase the risk of heart disease but against which both statins and the new drug are similarly ineffective
B. Whether the standards for what constitutes high cholesterol have been constant in the years before and after the clinical trial
C. Whether the typical treatment for elevated cholesterol levels tends to be more costly than typical treatments for related conditions
D. Whether most of the patients in the clinical trial continued to take more statins than was necessary
E. Whether, for most patients in the clinical trial, high cholesterol is their most pressing health concern

_________________

Thanks!
Do give some kudos.

Simple strategy:
“Once you’ve eliminated the impossible, whatever remains, however improbable, must be the truth.”

Want to improve your Score:
GMAT Ninja YouTube! Series 1| GMAT Ninja YouTube! Series 2

My Notes:
Reading comprehension | Critical Reasoning | Absolute Phrases

Intern
Intern
avatar
B
Joined: 22 May 2015
Posts: 6
Location: Peru
GMAT 1: 700 Q50 V34
GPA: 3.55
Reviews Badge CAT Tests
Re: A new drug to lower cholesterol has entered the market that,  [#permalink]

Show Tags

New post 04 Mar 2018, 16:07
D, if they took more statins than was necessary then the total cost (+the new drug) would not surpassed healthcare costs
GMAT Club Bot
Re: A new drug to lower cholesterol has entered the market that, &nbs [#permalink] 04 Mar 2018, 16:07
Display posts from previous: Sort by

A new drug to lower cholesterol has entered the market that,

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  


Copyright

GMAT Club MBA Forum Home| About| Terms and Conditions and Privacy Policy| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.